Early research (Phase 1)Study completedNCT02020434
What this trial is testing
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Who this might be right for
Subjects With Varying Degrees of Renal Insufficiency andSubjects With Normal Renal Function
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 32